Home » Newsletters » BioWorld Asia

BioWorld Asia

June 21, 2000

View Archived Issues

Qiagen Acquiring Operon In Stock Deal Valued At $110M

EU Ministers Take Steps To Promote European Research

French Oppose Commission Directive On Biotech Patents

NsGene, Biogen Collaborate In Neublastin Deal Worth $20M

Kirkman Seeks Greater Role For BIA As He Assumes Top Position

Recap Of Deals, Financings Now Available From BioWorld

GPC Biotech, Karo Collaborate To Identify Novel Antibiotics

Commissioner Says Industry Brought GMO Flap On Itself

OECD Report To G8 Calls For Harmonization Of Regulations

Lorantis Completing First Round To Fund Program Around Notch

QBI Plans IPO As Biotech In Israel Gets Venture Boost

Other News To Note

Bioniche Identifies New Class Of Molecules Against Cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...